PTC Therapeutics (PTCT) PT Raised to $37 at Goldman Sachs, 'stock in an increasingly precarious position ahead of higher risk'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. MU

Go back to PTC Therapeutics (PTCT) PT Raised to $37 at Goldman Sachs, 'stock in an increasingly precarious position ahead of higher risk'

PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

May 17, 2023 7:00 AM EDT

- Highly statistically significant and clinically meaningful results -

- 63% mean blood Phe reduction in primary analysis population (p... More